Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123423
Filing Date
2024-11-07
Accepted
2024-11-07 16:30:29
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20240930.htm   iXBRL 10-Q 2529170
2 EX-31.1 adpt-ex31_1.htm EX-31.1 17620
3 EX-31.2 adpt-ex31_2.htm EX-31.2 17614
4 EX-32.1 adpt-ex32_1.htm EX-32.1 10512
5 EX-32.2 adpt-ex32_2.htm EX-32.2 11683
  Complete submission text file 0000950170-24-123423.txt   10157860

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20240930.xsd EX-101.SCH 1195605
79 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20240930_htm.xml XML 2071417
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 241436350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)